Last $6.86 USD
Change Today +0.23 / 3.47%
Volume 553.8K
SCLN On Other Exchanges
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Lotter

Chief Executive Officer, President and Director, NovaMed Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships


Mr. Mark Lotter served as the Chief Executive Officer of China Operations at SciClone Pharmaceuticals, Inc., from April 2011 to December 14, 2012. Mr. Lotter serves as the Chief Executive Officer and President of NovaMed Pharmaceuticals Inc. Prior to founding NovaMed, Mr. Lotter served as Vice President, Commercial Operations of AstraZeneca China. He was largely responsible for turning AstraZeneca to the largest prescription based multinational in China. He served as ...

Read Full Background

Corporate Headquarters*

950 Tower Lane
Foster City, California 94404

United States

Phone: 650-358-3456
Fax: 650-358-3469

Board Members Memberships*

Chief Executive Officer, President and Director
Former Chief Executive Officer of China Operations and Director


The University of KwaZulu-Natal
University of South Africa

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SCLN:US $6.86 USD +0.23


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SCICLONE PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at